# Nanjing White Whale Pharmaceutical Co., Ltd. – FDA Inspection, Jul 21, 2017

Source: https://www.keypedia.com/records/fda_inspections/nanjing-white-whale-pharmaceutical-co-ltd/701350ce-be1f-40fa-9bd5-fc4b3e9e5672
Source feed: FDA_Inspections

> FDA inspection 1020941 of Nanjing White Whale Pharmaceutical Co., Ltd., July 21, 2017. Classification: Voluntary Action Indicated (VAI). Form 483 issued. 3 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1020941
- Company Name: Nanjing White Whale Pharmaceutical Co., Ltd.
- Inspection Date: 2017-07-21
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Center: Human Drugs
- Office Name: Center for Drug Evaluation and Research
- Citation Count: 0

## Related Documents

- [FDA Inspection 1228562 - 2024-01-25](https://www.keypedia.com/records/fda_inspections/nanjing-white-whale-pharmaceutical-co-ltd/739a104a-ac89-4523-97ef-464b93c0d257)
- FDA Inspection 898126 - 2014-09-19
- FDA Inspection 728992 - 2011-06-10

## Related Officers

- [Christopher S. Keating](https://www.keypedia.com/people/christopher-s-keating/94fcfd32-feb5-4b6c-80da-16202f4be01d)

Company: https://www.keypedia.com/companies/nanjing-white-whale-pharmaceutical-co-ltd/b162a593-aef1-42bb-bfa7-ca247b3567fa

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c